Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study

被引：0
|
作者：
Otte, C. [1 ]
Hinkelmann, K. [1 ]
Moritz, S. [1 ]
Yassouridis, A. [2 ]
Jahn, H. [1 ]
Wiedemann, K. [1 ]
Kellner, M. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat, Hamburg, Germany
[2] Max Planck Inst Psychiat, D-80804 Munich, Germany
来源：
PHARMACOPSYCHIATRY | 2009年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A120
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [21] Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial
    Hobbs, Adrian J.
    Moyes, Amie J.
    Baliga, Reshma S.
    Ghedia, Dipa
    Ochiel, Rachel
    Sylvestre, Yvonne
    Dore, Caroline J.
    Chowdhury, Kashfia
    Maclagan, Kate
    Quartly, Harriet L.
    Sofat, Reecha
    Smit, Angelique
    Schreiber, Benjamin E.
    Coghlan, Gerry J.
    MacAllister, Raymond J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (09) : 1251 - 1267
  • [22] Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study
    Kanchanatawan, Buranee
    Tangwongchai, Sookjaroen
    Sughondhabhirom, Atapol
    Suppapitiporn, Siriluck
    Hemrunrojn, Solaphat
    Carvalho, Andre F.
    Maes, Michael
    NEUROTOXICITY RESEARCH, 2018, 33 (03) : 621 - 633
  • [23] Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study
    Buranee Kanchanatawan
    Sookjaroen Tangwongchai
    Atapol Sughondhabhirom
    Siriluck Suppapitiporn
    Solaphat Hemrunrojn
    André F. Carvalho
    Michael Maes
    Neurotoxicity Research, 2018, 33 : 621 - 633
  • [24] Efficacy of pentoxifylline for the treatment of bipolar I/II patients with treatment-resistant depression: A proof-of-concept, randomized, double-blind, placebo-controlled trial
    Mohammad, Tavgah Ahmed Merza
    Mohammad, Talar Ahmed Merza
    Shawis, Teshk Nouri
    BRAIN RESEARCH BULLETIN, 2024, 216
  • [25] Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
    Domany, Yoav
    Bleich-Cohen, Maya
    Tarrasch, Ricardo
    Meidan, Roi
    Litvak-Lazar, Olga
    Stoppleman, Nadav
    Schreiber, Shaul
    Bloch, Miki
    Hendler, Talma
    Sharon, Haggai
    BRITISH JOURNAL OF PSYCHIATRY, 2019, 214 (01) : 20 - 26
  • [26] Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
    Zwiep, J. C.
    Bet, P. M.
    Rhebergen, D.
    Nurmohamed, M. T.
    Vinkers, C. H.
    Penninx, B. W. J. H.
    Milaneschi, Y.
    Lamers, F.
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2023, 27
  • [27] Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression
    Fava, Maurizio
    Mazzone, Erica
    Freeman, Marlene
    Flynn, Martina
    Judge, Heidi
    Hoeppner, Bettina
    Hock, Rebecca S.
    Shui, Amy
    Macaluso, Matthew
    Morrison, Mary F.
    Carpenter, Linda L.
    Shelton, Richard
    Zajecka, John
    Papakostas, George, I
    ANNALS OF CLINICAL PSYCHIATRY, 2021, 33 (01) : 18 - 26
  • [28] Acute beetroot juice supplementation on sympathetic nerve activity: a randomized, double-blind, placebo-controlled proof-of-concept study
    Notay, Karambir
    Incognito, Anthony V.
    Millar, Philip J.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 313 (01): : H59 - H65
  • [29] A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder
    Brown, E. Sherwood
    McArdle, Meagan
    Palka, Jayme
    Bice, Collette
    Ivleva, Elena
    Nakamura, Alyson
    McNutt, Markey
    Patel, Zena
    Holmes, Traci
    Tipton, Shane
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 43 : 92 - 101
  • [30] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED ADD-ON TRIAL OF LAMOTRIGINE IN PATIENTS WITH SEVERE EPILEPSY
    SANDER, JWAS
    PATSALOS, PN
    OXLEY, JR
    HAMILTON, MJ
    YUEN, WC
    EPILEPSY RESEARCH, 1990, 6 (03) : 221 - 226
12345